C0015732||faecal incontinence
C0036421||systemic sclerosis
C0015732||faecal incontinence
C0015732||faecal incontinence
C0036421||SSc
C0021853||intestinal
C0015732||faecal incontinence
C0010362||cross-sectional study
C0036421||SSc
C1708333||Canadian Scleroderma Research Group
C0599755||cohort
C0034394||questionnaires
C0349674||Jorge-Wexner score
C0015732||faecal incontinence
C0681887||severity scale
C4084861||Bristol stool scale
C0426740||stool consistency
C0015732||faecal incontinence
C0451401||Quality-of-Life scale
C0009806||Constipation
C0679228||Rome III criteria
C0349674||Jorge-Wexner score
C1836458||clinical variables
C0034980||multivariate regression analyses
C0015732||faecal incontinence
C0015733||stools
C0009806||constipation
C3160854||small intestinal bacterial overgrowth
C3160854||small intestinal bacterial overgrowth
C0015732||faecal incontinence
C2129214||loose
C0015733||stools
C0009806||constipation
C3160854||small intestinal bacterial overgrowth
C0042024||urinary incontinence
C0015732||faecal incontinence
C0451401||Quality-of-Life scale
C0015732||faecal incontinence
C0015732||faecal incontinence
C0036421||SSc
C2129214||Loose stools
C3160854||small intestinal bacterial overgrowth
C0009806||constipation
C0042024||urinary incontinence
C0015732||faecal incontinence
C0277785||dysfunction
C0087111||treatment
C0015732||faecal incontinence
C0036421||SSc